CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Income Statement [Abstract]
Net service revenue	$ 545,257	$ 537,144
Other operating income	0	8,701
Cost of service, excluding depreciation and amortization	304,820	297,203
General and administrative expenses:
Salaries and benefits	123,480	115,825
Non-cash compensation	7,347	7,307
Other	53,640	49,106
Depreciation and amortization	8,008	7,555
Operating expenses	497,295	476,996
Operating income	47,962	68,849
Other income (expense):
Interest income	13	24
Interest expense	(3,173)	(2,072)
Equity in (loss) earnings from equity method investments	(1,403)	1,118
Miscellaneous, net	333	288
Total other expense, net	(4,230)	(642)
Income before income taxes	43,732	68,207
Income tax expense	(12,019)	(17,915)
Net income	31,713	50,292
Net income attributable to noncontrolling interests	(42)	(422)
Net income attributable to Amedisys, Inc.	$ 31,671	$ 49,870
Basic earnings per common share:
Net income attributable to Amedisys, Inc. common stockholders, basic (usd per share)	$ 0.97	$ 1.52
Weighted average shares outstanding, basic (shares)	32,555	32,780
Diluted earnings per common share:
Net income attributable to Amedisys, Inc. common stockholders, diluted (usd per share)	$ 0.97	$ 1.50
Weighted average shares outstanding, diluted (shares)	32,766	33,190